XML 22 R11.htm IDEA: XBRL DOCUMENT v3.25.3
Revenue (Notes)
 3 Months Ended
Sep. 30, 2025
Revenue from Contract with Customer [Abstract]  
Revenue REVENUE
Remaining Performance Obligations
Remaining performance obligations represent the transaction price allocated to unsatisfied or partially unsatisfied performance obligations. The company applies the practical expedient to disclose the transaction price allocated to the remaining performance obligations for only those contracts with an original duration of more than one year. The transaction price allocated to remaining performance obligations with an original duration of more than one year related to material rights granted to customers for contract renewal options were $147 million, $139 million and $140 million at September 30, 2025, December 31, 2024 and September 30, 2024, respectively. The company expects revenue to be recognized for the remaining performance obligations evenly over the period of one year to six years.

Contract Balances
Contract liabilities primarily reflect deferred revenue from prepayments under contracts with customers where the company receives advance payments for products to be delivered in future periods. Corteva classifies deferred revenue as current or noncurrent based on the timing of when the company expects to recognize revenue. Contract assets primarily include amounts related to conditional rights to consideration for completed performance not yet invoiced. Accounts receivable are recorded when the right to consideration becomes unconditional.

Contract BalancesSeptember 30, 2025December 31, 2024September 30, 2024
(In millions)
Accounts and notes receivable - trade1
$6,428 $4,615 $5,501 
Contract assets - current2
$33 $30 $29 
Contract assets - noncurrent3
$81 $74 $73 
Deferred revenue - current$483 $3,287 $429 
Deferred revenue - noncurrent4
$123 $114 $115 
1.Included in accounts and notes receivable - net in the interim Consolidated Balance Sheets.
2.Included in other current assets in the interim Consolidated Balance Sheets.
3.Included in other assets in the interim Consolidated Balance Sheets.
4.Included in other noncurrent obligations in the interim Consolidated Balance Sheets.

Revenue recognized during the nine months ended September 30, 2025 and 2024 from amounts included in deferred revenue at the beginning of the period was $3,202 million and $3,314 million, respectively.
Disaggregation of Revenue
Corteva's operations are classified into two reportable segments: Seed and Crop Protection. The company disaggregates its revenue by major product line and geographic region, as the company believes it best depicts the nature, amount and timing of its revenue and cash flows. Net sales by major product line are included below:
Three Months Ended September 30,Nine Months Ended September 30,
(In millions)2025202420252024
    Corn$586 $315 $5,616 $5,085 
    Soybean152 164 1,714 1,773 
    Other oilseeds141 135 550 566 
    Other38 77 281 349 
Seed917 691 8,161 7,773 
    Herbicides813 736 2,668 2,568 
    Insecticides409 437 1,181 1,225 
    Fungicides222 216 868 761 
    Biologicals147 135 328 307 
    Other110 111 285 296 
Crop Protection1,701 1,635 5,330 5,157 
Total$2,618 $2,326 $13,491 $12,930 

Sales are attributed to geographic regions based on customer location. Net sales by geographic region and segment are included below:
SeedThree Months Ended September 30,Nine Months Ended September 30,
(In millions)2025202420252024
North America1
$175 $170 $5,726 $5,394 
EMEA2
262 196 1,370 1,365 
Latin America391 218 730 696 
Asia Pacific89 107 335 318 
Total$917 $691 $8,161 $7,773 

Crop ProtectionThree Months Ended September 30,Nine Months Ended
September 30,
(In millions)2025202420252024
North America1
$532 $440 $1,820 $1,703 
EMEA2
200 219 1,316 1,311 
Latin America770 771 1,545 1,458 
Asia Pacific199 205 649 685 
Total$1,701 $1,635 $5,330 $5,157 
1.Represents U.S. & Canada.
2.Europe, Middle East and Africa ("EMEA").